Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
OA02 - A New Vision of Targets and Strategies
- 10:30 - 12:00
- 9/08/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Targeted Therapy
- Moderators:Frank Griesinger, Luis Paz-Ares
-
+
OA02.06 - The Sequential Therapy of Crizotinib Followed by Alectinib: Real World Data of 840 Patients with NSCLC Harboring ALK-Rearrangement (WJOG9516L)
11:25 - 11:35 | Presenter: Satomi Watanabe | Author(s): Takeharu Yamanaka, Kentaro Ito, Shinya Sakata, Haruko Daga, Takashi Kijima, Katsuya Hirano, Isamu Okamoto, Atsushi Nakamura, TOSHIYUKI Kozuki, Mikiko Ishihara, Koichi Azuma, Takashi Seto, Toshihide Yokoyama, Yuko Oya, Haruki Kobayashi, Kazumi Nishino, Yoshihiro Hattori, Kazuhiko Nakagawa, Nobuyuki Yamamoto
- Abstract
Loading...
-
+
EP1.14 - Targeted Therapy
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
EP1.14-08 - Irreversible Severe Cardiotoxicities Except for QTc Interval Prolongation Associated with Osimertinib
08:00 - 08:00 | Presenter: Kei Kunimasa | Author(s): Madoka Kimura, Takako Inoue, Motohiro Tamiya, Kazumi Nishino, Fumio Imamura, Toru Kumagai
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-57 - Association of Initial PD-L1 Expression with T790M-Acquired Resistance in Advanced EGFR-Mutant Lung Adenocarcinoma Patients
09:45 - 09:45 | Presenter: Kazumi Nishino | Author(s): Aki Kubota, Kei Kunimasa, Madoka Kimura, Takako Inoue, Motohiro Tamiya, Hanako Kuhara, Toru Kumagai
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-62 - Nomogram Based on Multivariable Regression Model Estimates the Overall Survival of Nivolumab for Previously Treated Advanced NSCLC
09:45 - 09:45 | Presenter: Motohiro Tamiya | Author(s): Akihiro Tamiya, Hirofumi Go, Takako Inoue, Madoka Kimura, Kei Kunimasa, Kenji Nakahama, Yoshihiko Taniguchi, Takayuki Shiroyama, Shun-ichi Isa, Kazumi Nishino, Toru Kumagai, Hidekazu Suzuki, Shinji Atagi, Tomonori Hirashima, Ayumi Shintani, Fumio Imamura
- Abstract
Loading... -
+
P1.04-77 - Efficacy of Anti-PD-1/L1 Therapy for Advanced Non-Small Cell Lung Cancer with Preexisting Autoimmune Markers
09:45 - 09:45 | Presenter: Takako Inoue | Author(s): Madoka Kimura, Kei Kunimasa, Motohiro Tamiya, Hanako Kuhara, Kazumi Nishino, Terutaka Hino, Toru Kumagai
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P2.14-23 - Initial Analysis in NSCLC Part of Randomized Trial Evaluating Topical Corticosteroid for the Facial Acneiform Rash by EGFR Inhibitors
10:15 - 10:15 | Presenter: Yutaka Fujiwara | Author(s): Kazumi Nishino, Motohiro Tamiya, Katsuko Kikuchi, Ryota Saito, Tetsu Kobayashi, Tetsuya Hamaguchi, Keiko Nozawa, Haruhiko Fukuda, Yoshio Kiyohara, Naoya Yamazaki
- Abstract
Loading...
-
+
P2.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
P2.16-19 - Real World Data in Non-Small Cell Lung Cancer with Activating EGFR Mutation - A Multicenter Observational Study
10:15 - 10:15 | Presenter: Madoka Kimura | Author(s): Kazumi Nishino, Yukihiro Yano, Masahide Mori, Hidekazu Suzuki, Tomonori Hirashima, Seigo Minami, Kiyoshi Komuta, Takayuki Shiroyama, Izumi Nagatomo, Fumio Imamura
- Abstract
Loading...